Literature DB >> 33384200

Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission.

Hendrik Van Poppel1, Renée Hogenhout2, Peter Albers3, Roderick C N van den Bergh4, Jelle O Barentsz5, Monique J Roobol2.   

Abstract

The burden of prostate cancer is increasing. Therefore, we need to implement a contemporary, organized, risk-stratified program for early detection to reduce both the harm from the disease and potential overdiagnosis and overtreatment, while avoiding underdiagnosis to considerably improve the harm-to-benefit ratio.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2020        PMID： 33384200     DOI： 10.1016/j.eururo.2020.12.010

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  10 in total

1.  External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort.

Authors:  Marinus J Hagens; Piter J Stelwagen; Hans Veerman; Sybren P Rynja; Martijn Smeenge; Vincent van der Noort; Ton A Roeleveld; Jolien van Kesteren; Sebastiaan Remmers; Monique J Roobol; Pim J van Leeuwen; Henk G van der Poel
Journal:  World J Urol       Date:  2022-10-16       Impact factor: 3.661

2.  Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer.

Authors:  Edmund M Qiao; Julie A Lynch; Kyung M Lee; Nikhil V Kotha; Vinit Nalawade; Rohith S Voora; Alexander S Qian; Tyler J Nelson; Kosj Yamoah; Isla P Garraway; Tyler F Stewart; J Kellogg Parsons; Brent S Rose
Journal:  J Natl Cancer Inst       Date:  2022-04-11       Impact factor: 11.816

Review 3.  The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers.

Authors:  Catarina Leitão; Bárbara Matos; Fátima Roque; Maria Teresa Herdeiro; Margarida Fardilha
Journal:  J Clin Med       Date:  2022-05-22       Impact factor: 4.964

4.  Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data.

Authors:  Sebastiaan Remmers; Veeru Kasivisvanathan; Jan F M Verbeek; Caroline M Moore; Monique J Roobol
Journal:  Eur Urol Open Sci       Date:  2021-12-15

5.  Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI.

Authors:  Elena Bertelli; Laura Mercatelli; Chiara Marzi; Eva Pachetti; Michela Baccini; Andrea Barucci; Sara Colantonio; Luca Gherardini; Lorenzo Lattavo; Maria Antonietta Pascali; Simone Agostini; Vittorio Miele
Journal:  Front Oncol       Date:  2022-01-13       Impact factor: 6.244

6.  Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy.

Authors:  Sebastiaan Remmers; Daan Nieboer; L Lucia Rijstenberg; Tim Hansum; Geert J L H van Leenders; Monique J Roobol
Journal:  Eur Urol Open Sci       Date:  2021-12-17

7.  Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy.

Authors:  Alexander Kretschmer; Holger Kajau; Eric Margolis; Ronald Tutrone; Tobias Grimm; Matthias Trottmann; Christian Stief; Georg Stoll; Christian A Fischer; Claudia Flinspach; Anja Albrecht; Lisa Meyer; Tina Priewasser; Daniel Enderle; Romy Müller; Phillipp Torkler; Jason Alter; Johan Skog; Mikkel Noerholm
Journal:  Sci Rep       Date:  2022-03-21       Impact factor: 4.379

8.  Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer.

Authors:  Nagjie Alijaj; Blaz Pavlovic; Paul Martel; Arnas Rakauskas; Valérie Cesson; Karim Saba; Thomas Hermanns; Pascal Oechslin; Markus Veit; Maurizio Provenzano; Jan H Rüschoff; Muriel D Brada; Niels J Rupp; Cédric Poyet; Laurent Derré; Massimo Valerio; Irina Banzola; Daniel Eberli
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

9.  Early Detection of Prostate Cancer: Self-Reported Knowledge and Attitude of Physicians in Jordan.

Authors:  Mohammad A Y Alqudah; Raneem Al-Samman; Obada Matalgah; Rana Abu Farhah
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

10.  Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions.

Authors:  Michela Gravina; Lorenzo Spirito; Giuseppe Celentano; Marco Capece; Massimiliano Creta; Gianluigi Califano; Claudia Collà Ruvolo; Simone Morra; Massimo Imbriaco; Francesco Di Bello; Antonio Sciuto; Renato Cuocolo; Luigi Napolitano; Roberto La Rocca; Vincenzo Mirone; Carlo Sansone; Nicola Longo
Journal:  Diagnostics (Basel)       Date:  2022-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.